204 related articles for article (PubMed ID: 11710745)
1. Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D3 preferring antagonist PNU-99194a: an analysis of possible mechanisms.
Goudie AJ; Baker LE; Smith JA; Prus AJ; Svensson KA; Cortes-Burgos LA; Wong EH; Haadsma-Svensson S
Behav Pharmacol; 2001 Sep; 12(5):303-15. PubMed ID: 11710745
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: comparison with psychomotor stimulants.
Baker LE; Miller ME; Svensson KA
Behav Pharmacol; 1997 Jun; 8(2-3):243-52. PubMed ID: 9833019
[TBL] [Abstract][Full Text] [Related]
3. Reevaluation of PNU-99194A discriminative stimulus effects: potentiation by both a D2 antagonist and a D3/D2 agonist.
Baker LE; Prus AJ
Pharmacol Biochem Behav; 2002 Nov; 73(4):753-8. PubMed ID: 12213519
[TBL] [Abstract][Full Text] [Related]
4. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine.
Baker LE; Svensson KA; Garner KJ; Goodwin AK
Eur J Pharmacol; 1998 Oct; 358(2):101-9. PubMed ID: 9808258
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus properties of the dopamine D3 antagonist PNU-99194A.
Franklin SR; Baker LE; Svensson KA
Psychopharmacology (Berl); 1998 Jul; 138(1):40-6. PubMed ID: 9694525
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus properties of the atypical neuroleptic clozapine in rats: tests with subtype selective receptor ligands.
Goudie AJ; Smith JA; Taylor A; Taylor MA; Tricklebank MD
Behav Pharmacol; 1998 Dec; 9(8):699-710. PubMed ID: 9890260
[TBL] [Abstract][Full Text] [Related]
7. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.
Garner KJ; Baker LE
Pharmacol Biochem Behav; 1999 Oct; 64(2):373-8. PubMed ID: 10515316
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A.
Christian AJ; Goodwin AK; Baker LE
Pharmacol Biochem Behav; 2001 Mar; 68(3):371-7. PubMed ID: 11325388
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms.
Prus AJ; Baker LE; Meltzer HY
Pharmacol Biochem Behav; 2004 Feb; 77(2):199-208. PubMed ID: 14751446
[TBL] [Abstract][Full Text] [Related]
10. The D3 antagonist PNU-99194A potentiates the discriminative cue produced by the D3 agonist 7-OH-DPAT.
Depoortere R; Perrault G; Sanger DJ
Pharmacol Biochem Behav; 2000 Jan; 65(1):31-4. PubMed ID: 10638632
[TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicle.
Prus AJ; Philibin SD; Pehrson AL; Porter JH
Behav Pharmacol; 2006 Mar; 17(2):185-94. PubMed ID: 16495726
[TBL] [Abstract][Full Text] [Related]
12. The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats.
Kelley BM; Porter JH
Pharmacol Biochem Behav; 1997 Aug; 57(4):707-19. PubMed ID: 9258998
[TBL] [Abstract][Full Text] [Related]
13. Assessment of D3 versus D2 receptor modulation of the discriminative stimulus effects of (+)-7-OH-DPAT in rats.
Baker LE; Hood CA; Heidema AM
Behav Pharmacol; 1999 Dec; 10(8):717-22. PubMed ID: 10780286
[TBL] [Abstract][Full Text] [Related]
14. S-16924, a novel, potential antipsychotic with marked serotonin1A agonist properties. IV. A drug discrimination comparison with clozapine.
Millan MJ; Schreiber R; Monneyron S; Denorme B; Melon C; Queriaux S; Dekeyne A
J Pharmacol Exp Ther; 1999 Apr; 289(1):427-36. PubMed ID: 10087034
[TBL] [Abstract][Full Text] [Related]
15. Effects of the putative dopamine D3 receptor antagonist PNU 99194A on motor behavior and emotional reactivity in C57BL/6J mice.
Gendreau PL; Petitto JM; Schnauss R; Frantz KJ; Van Hartesveldt C; Gariépy JL; Lewis MH
Eur J Pharmacol; 1997 Oct; 337(2-3):147-55. PubMed ID: 9430408
[TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
Millan MJ; Iob L; Péglion JL; Dekeyne A
Psychopharmacology (Berl); 2007 Apr; 191(3):767-82. PubMed ID: 17047933
[TBL] [Abstract][Full Text] [Related]
17. Both dopamine and the putative dopamine D3 receptor antagonist PNU-99194A induce a biphasic inhibition of phorbol ester-stimulated arachidonic acid release from CHO cells transfected with the dopamine D3 receptor.
Nilsson CL; Hellstrand M; Ekman A; Eriksson E
Life Sci; 1999; 64(11):939-51. PubMed ID: 10201643
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine.
Goudie AJ; Smith JA; Millan MJ
Psychopharmacology (Berl); 2004 Jan; 171(2):212-22. PubMed ID: 14691616
[TBL] [Abstract][Full Text] [Related]
19. Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice.
Philibin SD; Prus AJ; Pehrson AL; Porter JH
Psychopharmacology (Berl); 2005 Jun; 180(1):49-56. PubMed ID: 15696329
[TBL] [Abstract][Full Text] [Related]
20. Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.
Gyertyán I; Sághy K
Behav Pharmacol; 2004 Jul; 15(4):253-62. PubMed ID: 15252275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
